Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Thom de Milliano"'
Publikováno v:
Cancer Research. 82:P3-23
Introduction: Among the molecular subtypes of breast cancer, HER2-negative is the most common, accounting for around ~80% of all cases. Over the last five years, the HER2-negative metastatic breast cancer (mBC) treatment landscape has evolved substan